Gofen & Glossberg LLC Novartis Ag Transaction History

Gofen & Glossberg LLC

$3.89 Billion
Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Novartis Ag stock. As of the latest transaction made, Gofen & Glossberg LLC holds 227,555 shares of NVS stock, worth $26.5 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

227,555

Previous 231,989 1.91%

Holding current value

$26.5 Million

Previous $17.6 Million 17.07%

% of portfolio

0.53%

Previous 0.5%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$75.55 - $92.52 $334,988 - $410,233	-4,434 Reduced 1.91%	227,555 $20.6 Million
Q3 2022 Oct 13, 2022	SELL	$74.61 - $87.26 $183,316 - $214,397	-2,457 Reduced 1.05%	231,989 $17.6 Million
Q2 2022 Jul 14, 2022	SELL	$80.52 - $93.75 $1.08 Million - $1.25 Million	-13,373 Reduced 5.4%	234,446 $19.8 Million
Q1 2022 Apr 14, 2022	SELL	$80.11 - $90.62 $1.33 Million - $1.5 Million	-16,569 Reduced 6.27%	247,819 $21.7 Million
Q4 2021 Jan 25, 2022	SELL	$79.7 - $88.13 $52,044 - $57,548	-653 Reduced 0.25%	264,388 $23.1 Million
Q3 2021 Oct 13, 2021	SELL	$81.78 - $95.14 $171,738 - $199,794	-2,100 Reduced 0.79%	265,041 $21.7 Million
Q2 2021 Jul 13, 2021	SELL	$85.24 - $94.15 $18,923 - $20,901	-222 Reduced 0.08%	267,141 $24.4 Million
Q1 2021 Apr 13, 2021	BUY	$83.5 - $98.47 $514,109 - $606,279	6,157 Added 2.36%	267,363 $22.9 Million
Q4 2020 Jan 15, 2021	BUY	$78.07 - $94.43 $43,563 - $52,691	558 Added 0.21%	261,206 $24.7 Million
Q3 2020 Oct 09, 2020	BUY	$82.14 - $91.0 $487,008 - $539,539	5,929 Added 2.33%	260,648 $22.7 Million
Q1 2020 Apr 14, 2020	BUY	$70.67 - $99.01 $298,651 - $418,416	4,226 Added 1.69%	254,719 $21 Million
Q4 2019 Jan 28, 2020	BUY	$84.35 - $95.37 $141,961 - $160,507	1,683 Added 0.68%	250,493 $23.7 Million
Q3 2019 Oct 10, 2019	SELL	$85.54 - $94.26 $63,299 - $69,752	-740 Reduced 0.3%	248,810 $21.6 Million
Q2 2019 Jul 12, 2019	SELL	$75.4 - $92.8 $32,949 - $40,553	-437 Reduced 0.17%	249,550 $22.8 Million
Q1 2019 Apr 11, 2019	BUY	$75.32 - $86.15 $65,001 - $74,347	863 Added 0.35%	249,987 $24 Million
Q4 2018 Jan 15, 2019	SELL	$73.66 - $82.02 $45,227 - $50,360	-614 Reduced 0.25%	249,124 $21.4 Million
Q3 2018 Oct 11, 2018	SELL	$66.94 - $77.43 $148,138 - $171,352	-2,213 Reduced 0.88%	249,738 $21.5 Million
Q2 2018 Jul 11, 2018	BUY	$64.91 - $73.36 $200,182 - $226,242	3,084 Added 1.24%	251,951 $19 Million
Q1 2018 Apr 11, 2018	SELL	$70.39 - $84.15 $325,272 - $388,857	-4,621 Reduced 1.82%	248,867 $20.1 Million
Q4 2017 Jan 11, 2018	BUY	$72.33 - $77.64 $28,787 - $30,900	398 Added 0.16%	253,488 $21.3 Million
Q3 2017 Nov 16, 2017	SELL	$74.14 - $77.27 $420,966 - $438,739	-5,678 Reduced 2.19%	253,090 $21.7 Million
Q2 2017 Aug 16, 2017	BUY	N/A	258,768	258,768 $21.6 Million

Others Institutions Holding NVS

# of Institutions

1,425

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $251B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Account

Gofen & Glossberg LLC Novartis Ag Transaction History